Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03269370 · ClinicalTrials.gov registry record · NA

Family-Focused CBT Skills App and Standard Self Help Options for Childhood Anxiety

A NA study of Anxiety and Anxiety Disorders, sponsored by Kansas City Center for Anxiety Treatment, P.A..

Completed
Registry status
NA
Development phase
110
Enrollment target
1
Study location

NCT03269370: Completed NA study of Anxiety and Anxiety Disorders, sponsored by Kansas City Center for Anxiety Treatment, P.A..

NCT03269370 is a NA study of Anxiety and Anxiety Disorders that has completed, run by Kansas City Center for Anxiety Treatment, P.A.. The registered enrollment target is 110 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03269370, a NA study of Anxiety and Anxiety Disorders, has completed, sponsored by Kansas City Center for Anxiety Treatment, P.A..

COMPLETED
Registry status
NA
Development phase
110 participants
Enrollment target
1
Study location

Study Summary

Anxiety disorders are among the most common psychological disorders, with prevalent onset in childhood and adolescence. While cognitive behavioral therapy (CBT) is considered the first-line treatment for pediatric anxiety, significant barriers remain in accessing CBT and other evidence-based treatments (EBTs), and credible self-help resources based in EBT concepts. This study evaluates a family-guided CBT game application (Anchors App), targeted to children ages 6-11 and their families, which focuses on delivering adaptive CBT-based coping skills to those who have sub-clinical to mild anxiety and related symptoms in a convenient and portable platform. Anchors App will be evaluated in two forms (standard and "parent-enhanced") in comparison to use of a self-help book or waitlist control. The rapid advancements in technology allows richer interactive capacity, content scalability, customizability, and subscription to a broader range of content, which this app capitalizes on in order to increase access to CBT skill concepts directly to pediatric stakeholder populations. If found to be effective, Anchors App has the opportunity to promote engagement of EBT concepts in every-day use through smartphone technology, and will change the landscape of mental health prevention and early intervention for children and families.

Primary Outcome

Parent and child report of anxiety with 6 DSM-IV criteria sub scales. Measuring change in reported anxiety levels in these 6 different domains over time.

Interventions

  • BEHAVIORAL Anchors Away
  • BEHAVIORAL Parent Enhanced Anchors Away
  • BEHAVIORAL Self-Help E-Book

Study Locations (1)

Kansas

  • Kansas City Center for Anxiety Treatment, P.A. - Overland Park

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2018-08-17
Est. Completion 2019-12-31
Phase NA

What the finished NCT03269370 record still lists

NCT03269370 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (75% lower).

The record links to 3 conditions, with Anxiety appearing as the primary indexed condition, and to 3 interventions - of which Anchors Away is the first listed.

NCT03269370 reports a single indexed study location in Kansas.

Frequently Asked Questions

What is clinical trial NCT03269370 about?

NCT03269370 is a clinical study titled "Family-Focused CBT Skills App and Standard Self Help Options for Childhood Anxiety". Anxiety disorders are among the most common psychological disorders, with prevalent onset in childhood and adolescence. While cognitive behavioral therapy (CBT) is considered the first-line treatment for pediatric anxiety, significant barriers remain in accessing CBT and other evidence-based treatme...

What is the current status of trial NCT03269370?

This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2018-08-17. Estimated completion is 2019-12-31.

What conditions does trial NCT03269370 study?

This clinical trial studies the following conditions: Anxiety, Anxiety Disorders, Childhood Mental Disorder.

What interventions are being tested in trial NCT03269370?

The interventions under investigation include: Anchors Away (BEHAVIORAL), Parent Enhanced Anchors Away (BEHAVIORAL), Self-Help E-Book (BEHAVIORAL).

Who is sponsoring clinical trial NCT03269370?

This trial is sponsored by Kansas City Center for Anxiety Treatment, P.A., which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03269370 being conducted?

This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03269370's enrollment target sits among peer trials

110 152nd of 364 higher than 211 of 364 other Anxiety trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01530373 · 110 participants · Phase 2

    Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients

  • NCT02379377 · 110 participants · Phase 1

    18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant

  • NCT02411773 · 110 participants · Phase 1

    Sympatholysis in Chronic Kidney Disease

  • NCT03190941 · 110 participants · Phase 1

    Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03269370, the US trial registry maintained by the National Library of Medicine. NCT03269370 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.